Abstract Body

Background

Thanks to the advent of combination antiretroviral therapy (cART), life expectancy has dramatically increased in people with HIV (PWH), and the spectrum of diseases related to HIV has shifted towards non-infectious chronic illnesses, including cardiopulmonary disorders. Pulmonary arterial hypertension (PAH) is amongst the most devastating cardiovascular complications of HIV. Pulmonary artery smooth muscle cells (PASMCs) are primary cell types that contribute to the remodeling of pulmonary vascular walls, a critical structural alteration and pathological feature for PAH. However, the etiopathology of pulmonary vascular remodeling has yet to be determined. 

Methods

Three mouse models of HIV and in vitro experimental studies were used to test whether HIV-derived proteins, which remain in circulation despite cART and well-controlled viremia, contribute to the development of PAH and identify the signaling pathways involved in PAH associated with HIV infection.

Results

The expression of HIV proteins in HIV-1 Tg26 mice promoted PAH in male and female mice with no sex differences. These cardiopulmonary alterations were also exacerbated with aging. Remarkably, bone marrow transplant (BMT) from Tg26 to wild-type (WT) mice fully recapitulated the cardiopulmonary phenotype of Tg26 mice, which supports a role for viral proteins derived from hematopoietic cells in PAH. RNA Sequencing identified a novel marker of PAH, Podocan-like protein 1 (Podnl1), whose levels are increased in both intact and BMT Tg26 mice lungs but, more importantly, in the lungs of PWH on cART. Overexpression of Podnl1 in PASMCs increased the levels of collagen-I and PCNA, markers of fibrosis and cell proliferation, respectively. Remarkably, HIV-Tat is the only viral protein detectable in peripheral blood mononuclear cells (PBMCs) obtained from PWH on cART and chronic treatment of mice with Tat reproduced the cardiopulmonary complications of intact and BMT Tg26 mice. In addition, treatment of PASMCs with HIV-Tat and exposure of discarded human pulmonary artery specimens to HIV-Tat elevated the Podnl1 expression. 

Conclusions

Together, our data identify HIV-Tat and Podnl1 as major contributors to pulmonary vascular remodeling related to HIV infection and provide potential new therapeutic avenues for the prevention of HIV-associated cardiopulmonary complications.

Table or Figure